Primo Chemicals Ltd Valuation Shifts Signal Renewed Price Attractiveness

Valuation Metrics Signal Improved Price Attractiveness

As of 18 May 2026, Primo Chemicals trades at a price of ₹24.04, down 4.07% from the previous close of ₹25.06. The stock’s 52-week range spans ₹16.21 to ₹31.44, indicating a moderate volatility band. The company’s price-to-earnings (P/E) ratio currently stands at 37.40, a level that has prompted a valuation grade upgrade from fair to attractive by MarketsMOJO. This is a significant development given the sector’s typical valuation range and the company’s historical P/E levels.

Complementing the P/E improvement, the price-to-book value (P/BV) ratio is at 1.43, which is relatively modest for a commodity chemicals firm, suggesting that the stock is trading close to its net asset value. This contrasts favourably with several peers in the industry, many of whom are rated as expensive or very expensive based on their P/E and EV/EBITDA multiples.

Peer Comparison Highlights Relative Value

When compared with its peer group, Primo Chemicals’ valuation metrics stand out for their relative attractiveness. For instance, Titan Biotech and Sanstar Chemicals are classified as very expensive, with P/E ratios of 68.8 and 94.16 respectively, and EV/EBITDA multiples exceeding 50 and 90. Stallion India, another peer, is also expensive with a P/E of 37.39 but a higher EV/EBITDA of 21.41, nearly double that of Primo Chemicals’ 10.38.

On the other hand, companies like Gulshan Polyols and TGV Sraac are rated very attractive, with P/E ratios of 28.08 and 9.36 and EV/EBITDA multiples of 12.18 and 4.24 respectively. Primo Chemicals’ valuation sits comfortably between these extremes, offering a balanced risk-reward profile for investors seeking exposure to the commodity chemicals sector without paying a premium.

Financial Performance and Quality Metrics

Despite the valuation upgrade, Primo Chemicals’ return on capital employed (ROCE) and return on equity (ROE) remain modest at 2.95% and 3.83% respectively. These figures indicate that while the company is generating returns above zero, it has yet to demonstrate strong profitability relative to capital invested. This may partly explain the cautious stance reflected in the Mojo Grade, which was upgraded from Sell to Hold on 5 May 2026, with a current Mojo Score of 64.0.

The enterprise value to EBIT ratio is elevated at 45.11, signalling that earnings before interest and tax are relatively low compared to the company’s overall valuation. However, the EV to EBITDA multiple of 10.38 is more reasonable and aligns with the company’s classification as attractive on valuation grounds. The PEG ratio of 0.11 further suggests that the stock is undervalued relative to its earnings growth potential, a positive sign for value-oriented investors.

Stock Price and Market Returns in Context

Primo Chemicals’ recent stock price performance has been mixed. Over the past week, the stock declined by 3.38%, slightly underperforming the Sensex’s 2.70% drop. However, over the last month, Primo Chemicals gained 2.82%, outperforming the Sensex which fell 3.68%. Year-to-date, the stock has marginally increased by 0.38%, while the Sensex has declined by 11.71%, reflecting relative resilience in a volatile market.

Longer-term returns tell a more nuanced story. Over one year, Primo Chemicals has declined 7.18%, slightly better than the Sensex’s 8.84% fall. However, over three years, the stock has underperformed significantly, falling 65.94% compared to the Sensex’s 20.68% gain. Conversely, over five and ten years, Primo Chemicals has delivered strong cumulative returns of 24.95% and an impressive 783.82% respectively, far outpacing the Sensex’s 54.39% and 195.17% gains. This highlights the stock’s volatile but potentially rewarding nature over extended periods.

Micro-Cap Status and Market Positioning

Primo Chemicals is classified as a micro-cap stock, which often entails higher volatility and risk but also the potential for outsized returns. The recent valuation upgrade to attractive and the Mojo Grade improvement to Hold reflect a cautious optimism about the company’s prospects. Investors should weigh these factors carefully, considering the company’s modest profitability metrics and the competitive pressures within the commodity chemicals sector.

Investment Implications and Outlook

The shift in Primo Chemicals’ valuation from fair to attractive suggests that the market is beginning to recognise value in the stock, particularly when viewed against its peer group and historical multiples. The relatively low PEG ratio and reasonable EV/EBITDA multiple support the case for a valuation rerating, especially if the company can improve its profitability metrics over time.

However, investors should remain mindful of the company’s modest ROCE and ROE, which indicate that operational efficiency and capital utilisation need to improve to sustain long-term growth. The stock’s micro-cap status also implies higher liquidity risk and price volatility, factors that should be considered in portfolio construction.

Given the mixed recent price performance and the broader commodity chemicals sector dynamics, a Hold rating appears prudent at this stage. The valuation upgrade provides a positive signal, but further fundamental improvements will be necessary to justify a more bullish stance.

Conclusion

Primo Chemicals Ltd’s recent valuation upgrade to attractive marks a significant development for investors tracking the commodity chemicals sector. With a P/E of 37.40 and a P/BV of 1.43, the stock offers a more compelling price point relative to many peers, some of which trade at steep premiums. While profitability metrics remain subdued, the company’s long-term return track record and improved valuation metrics provide a foundation for cautious optimism.

Investors should monitor upcoming earnings releases and sector trends closely to assess whether Primo Chemicals can translate its valuation appeal into sustained financial performance. Until then, the Hold rating and Mojo Score of 64.0 reflect a balanced view of risk and opportunity in this micro-cap stock.

Limited Period Only. Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Get 72% Off →